Emily S Gorell, DO, MS, FAAD
SESSIONS
F093 From Blisters to Breakthroughs: Updates in Epidermolysis Bullosa
Mar 30, 2026
•
1:00 PM - 3:00 PM
•
Bluebird 3A
DISCLOSURES
Abeona Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Amryt Pharma – Advisory Board(Honoraria); Chiesi – Advisory Board(Honoraria); Krystal Biotech, Inc – Advisory Board(Honoraria), Consultant(Honoraria);